The DSPM significantly suppressed both primary and distant tumor growth while enhancing antitumor immune responses when combined with radiotherapy.[65b] Although alternative timing or sequencing regimens were not explored, this study demonstrated that co‐delivery of a STING agonist and a radiosensitizer can improve therapeutic efficacy. This evidence concerns the gene STING1 and neoplasm.